EGFR and neoplasm: A second format of the HER1 VeraTagTM assay, which utilized an antibody directed against the ECD rather than the ICD of HER1, was run on a subset of 30/43 tumors upon which macrodissection of non-tumor elements were performed (see Materials and methods).